Drug: TOCILIZUMAB Injury: Hypersensitivity Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125063982 | TOCILIZUMAB | Hypersensitivity | AMGEN | 56.00 YR | F | 68 KG | 20160719 | US |
125510961 | Tocilizumab | Hypersensitivity | ROCHE | 39.00 MON | F | 14 KG | 20160713 | CN |
125555561 | Tocilizumab | Hypersensitivity | ROCHE | 0.00 | 0 | 20160714 | FR | |
126891321 | TOCILIZUMAB | Hypersensitivity | AMGEN | 34.00 YR | M | 0 | 20160826 | CA |
126949221 | TOCILIZUMAB | Hypersensitivity | PFIZER | 34.00 YR | M | 0 | 20160829 | CA |
127100111 | TOCILIZUMAB | Hypersensitivity | ORION | 34.00 YR | M | 0 | 20160902 | CA |
127338771 | Tocilizumab | Hypersensitivity | ROCHE | 34.00 YR | M | 0 | 20160912 | CA |
Total Records: 7 Number of Pages: 1